|
0
|
|
Efficacy of cefiderocol and levofloxacin against Stenotrophomonas maltophilia in a hemorrhagic pneumonia mouse model.
(journals.asm.org)
|
Imoto W
…
Kakeya H
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#modeling
#infection
#amr
#pneumonia
|
|
0
|
|
Spatiotemporal dynamics and multiple driving factors of antimicrobial resistance in China during the COVID-19 pandemic (2019-2023): a provincial panel data analysis.
(journals.asm.org)
|
Zheng X
…
Wu B
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#modeling
#infection
#amr
#epidemiology
|
|
0
|
|
The pharmacodynamics of polymyxin B in Acinetobacter baumannii in murine thigh and lung infection models.
(academic.oup.com)
|
van den Berg S
…
Muller AE
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#modeling
#infection
#amr
#pharmacodynamics
#antibiotic
|
|
0
|
|
Population pharmacokinetics of meropenem in critically ill adult patients receiving extracorporeal membrane oxygenation-an ASAP ECMO study.
(academic.oup.com)
|
Abdul-Aziz MH
…
Roberts JA
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#modeling
#dosing
#sepsis
#ecmo
|
|
0
|
|
Experimental biofilm models for pharmacokinetic and pharmacodynamic investigations: bridging in vitro, ex vivo and in vivo systems.
(academic.oup.com)
|
Supparitsch S
…
Zeitlinger M
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#modeling
#infection
#amr
#pharmacodynamics
#biofilm
|
|
0
|
|
Population pharmacokinetic model and dosing nomogram for daptomycin in adult patients with serious Gram-positive infections: emphasizing the role of loading doses and renal function-based adjustment.
(journals.asm.org)
|
Subrtova P
…
Sima M
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#modeling
#dosing
#infection
#amr
|
|
0
|
|
Evaluation of an in vivo pulmonary aspergillosis model for triazole susceptibility breakpoint development.
(journals.asm.org)
|
Lepak A
…
Andes D
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#modeling
#infection
#amr
#aspergillosis
|
|
0
|
|
Pharmacokinetic and pharmacodynamic modeling of anti-plasmodial drugs mefloquine plus artesunate: insights on translational application.
(journals.asm.org)
|
Mim SR
…
Azeredo FJ
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#modeling
#dosing
#malaria
#pharmacodynamics
|
|
0
|
|
Characteristics of individual cyp51A SNPs and combinations thereof impacting the azole phenotype in TR(34)-mediated resistance genotypes of Aspergillus fumigatus.
(journals.asm.org)
|
Song Y
…
Verweij PE
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#modeling
#infection
#amr
#mutation
|
|
0
|
|
A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant Achromobacter xylosoxidans.
(journals.asm.org)
|
Arun B
…
Rao G
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#modeling
#infection
#amr
#pharmacodynamics
#sequencing
|
|
0
|
|
Deep learning linking mechanistic models to single-cell transcriptomics data reveals transcriptional bursting in response to DNA damage.
(elifesciences.org)
|
Huang Z
…
Zhang J
eLife
2026-03-04
|
#modeling
#transcriptomics
#single-cell
#deep learning
#apoptosis
|
|
0
|
|
The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions.
(academic.oup.com)
|
van den Berg S
…
Meletiadis J
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#modeling
#dosing
#infection
#amr
#pharmacodynamics
|
|
0
|
|
Characterization of efflux pump channel of florfenicol for resistance-enhancing variant RE-CmeABC in Campylobacter.
(academic.oup.com)
|
Yao H
…
Yang L
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#modeling
#amr
#mutation
#campylobacter
|